SCHEMBL17633280

SCHEMBL17633280

O=C(O)N1C[C@H]2CC(Oc3ccccc3F)C[C@H]2C1

nearest known ligand 0.58

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 15/20 0.58
GRIN1 Q05586 14/20 0.58
RIPK1 Q13546 1/20 0.43
MGLL Q99685 2/20 0.42
HSD11B1 P28845 1/20 0.42
HSD11B2 P80365 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28383178 1.00 GRIN2B (0.58) GRIN2BGRIN1RIPK1MGLLHSD11B1
SCHEMBL17633359 1.00 GRIN2B (0.58) GRIN2BGRIN1RIPK1MGLLHSD11B1
SCHEMBL17633278 1.00 GRIN2B (0.58) GRIN2BGRIN1RIPK1MGLLHSD11B1
SCHEMBL29471127 0.82 GRIN1 (0.55) GRIN2BGRIN1
SCHEMBL17643339 0.82 GRIN1 (0.55) GRIN2BGRIN1
SCHEMBL15641032 0.81 USP30 (0.50) GRIN2BGRIN1
SCHEMBL15641030 0.81 USP30 (0.50) GRIN2BGRIN1
SCHEMBL17633323 0.80 GRIN1 (0.56) GRIN2BGRIN1RIPK1MGLL
SCHEMBL17633327 0.80 GRIN1 (0.56) GRIN2BGRIN1RIPK1MGLL
SCHEMBL27076410 0.80 GRIN1 (0.56) GRIN2BGRIN1RIPK1MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106795111-B N-alkylaryl-5-oxyaryl-octahydro-cyclopenta [ C ] pyrroles as negative allosteric modulators of NR2B 科登特治疗公司 2020-04-07 CN disclosed
EP-3197868-A1 N-ALKYLARYL-5-OXYARYL-OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE ALLOSTERIC MODULATORS OF NR2B Luc Therapeutics, Inc. (US) 2017-08-02 EP disclosed
WO-2016049165-A1 N-ALKYLARYL-5-OXYARYL-OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE ALLOSTERIC MODULATORS OF NR2B MNEMOSYNE PHARMACEUTICALS, INC. (US) 2016-03-31 WO disclosed